We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Board Erred In Shifting Burden To Patent Owner, Federal Circuit Rules

Mealey's (February 6, 2019, 1:57 PM EST) -- WASHINGTON, D.C. — A final written decision by the Patent Trial and Appeal Board that invalidated various claims of a patented prostate cancer treatment was vacated and remanded Feb. 5 by...
To view the full article, register now.